The invitae multi cancer panel is designed to maximize diagnostic yield for individuals with a personal or family history of mixed cancers affecting multiple organ systems.
Gene panel testing.
The genes we re born with may increase our risk for cancer.
Please contact client services with any questions.
The results of the test can inform your doctor about genes that may impact how you metabolize or respond to certain medications.
When finding the answer is critical for guiding your patient s healthcare cancernext is a comprehensive 36 gene panel that identifies inherited risks for at least 8 types of cancers giving you more information for treatment and management decisions.
A panel genetic test looks for changes in many genes in one test.
The genetic testing registry gtr provides a central location for voluntary submission of genetic test information by providers.
If you choose to add this test you will need to send in two sample tubes and your order will represent two billable events.
Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions.
Testing of at risk relatives for specific known variant s previously identified in an affected family member prenatal diagnosis for known familial pathogenic variant s in at risk pregnancies genetic counseling especially recurrence risk and prenatal diagnosis.
The scope includes the test s purpose methodology validity evidence of the test s usefulness and laboratory contacts and credentials.
Adding this test will result in an order that contains multiple clinical areas.
The exonic regions of 20 genes are sequenced and analyzed as part of this panel including adamts13 c2 c3 c3ar1 cd46 mcp cfb cfd cfh cfhr1 cfhr2 cfhr3 cfhr4 cfhr5 cfi dgke masp2 mmachc thbd plg wt1 and one snp in c5 c5 p arg885.
Your test results will be delivered as two reports.
Genetic testing panels are usually grouped in categories based on different kinds of medical concerns.
Thus gene panel testing is now an option in the setting of genetic counseling and testing for cancer ris next generation sequencing technologies have ushered in the capability to assess multiple genes in parallel for genetic alterations that may contribute to inherited risk for cancers in families.